Track topics on Twitter Track topics that are important to you
Moislinger Allee 53-55
Roche erhält für Hämophilie-Mittel Hemlibra in USA den Status Therapiedurchbruch Bayer: Temasek erhöht Anteil auf vier ProzentDrägerwerk wird nach schleppendem Jahresbeginn ein wenig zurückhalte...
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them 12.03.2018 / 07:29 The issuer is solely respon...
Drägerwerk AG & Co. KGaA / Key word(s): Quarter Results Drägerwerk AG & Co. KGaA: preliminary result for the first quarter 16-Apr-2018 / 18:46 CET/CEST Disclosure of an inside information ac...
DGAP-News: Drägerwerk AG & Co. KGaA / Key word(s): Preliminary Results 12.01.2018 / 16:29 The issuer is solely responsible for the content of this announcement. Drägerwerk AG & Co. KG...
Dräger Medical, A Dräger and Siemens Company, develops, manufactures and sells innovative products, services and integrated solutions for acute patient care and home care. The company's global portf...
A company history spanning over 110 years. Ever since the company was founded in the year 1889, Dräger has successfully faced up to the technological challenges of its markets. From the pressure redu...
TESCOM EUROPE offers customized solutions and services for all pressure and flow control applications. We design, engineer, manufacture and install components and automated systems for pressure and fl...
We have published hundreds of Drägerwerk AG news stories on BioPortfolio along with dozens of Drägerwerk AG Clinical Trials and PubMed Articles about Drägerwerk AG for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Drägerwerk AG Companies in our database. You can also find out about relevant Drägerwerk AG Drugs and Medications on this site too.